vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and INTERFACE INC (TILE). Click either name above to swap in a different company.
INTERFACE INC is the larger business by last-quarter revenue ($349.4M vs $263.6M, roughly 1.3× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 7.0%, a 7.9% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (9.8% vs 4.3%). Over the past eight quarters, INTERFACE INC's revenue compounded faster (9.8% CAGR vs 4.9%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Interface, Inc., headquartered in Atlanta, Georgia, is a global manufacturer of commercial flooring. The company sells modular carpet tiles, luxury vinyl tile, and Nora brand rubber flooring.
BCPC vs TILE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $349.4M |
| Net Profit | $39.2M | $24.4M |
| Gross Margin | 35.6% | 38.6% |
| Operating Margin | 19.8% | 10.1% |
| Net Margin | 14.9% | 7.0% |
| Revenue YoY | 9.8% | 4.3% |
| Net Profit YoY | 16.8% | 12.1% |
| EPS (diluted) | $1.21 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $349.4M | ||
| Q3 25 | $267.6M | $364.5M | ||
| Q2 25 | $255.5M | $375.5M | ||
| Q1 25 | $250.5M | $297.4M | ||
| Q4 24 | $240.0M | $335.0M | ||
| Q3 24 | $239.9M | $344.3M | ||
| Q2 24 | $234.1M | $346.6M | ||
| Q1 24 | $239.7M | $289.7M |
| Q4 25 | $39.2M | $24.4M | ||
| Q3 25 | $40.3M | $46.1M | ||
| Q2 25 | $38.3M | $32.6M | ||
| Q1 25 | $37.1M | $13.0M | ||
| Q4 24 | $33.6M | $21.8M | ||
| Q3 24 | $33.8M | $28.4M | ||
| Q2 24 | $32.1M | $22.6M | ||
| Q1 24 | $29.0M | $14.2M |
| Q4 25 | 35.6% | 38.6% | ||
| Q3 25 | 35.7% | 39.4% | ||
| Q2 25 | 36.4% | 39.4% | ||
| Q1 25 | 35.2% | 37.3% | ||
| Q4 24 | 36.0% | 36.5% | ||
| Q3 24 | 35.6% | 37.1% | ||
| Q2 24 | 35.5% | 35.4% | ||
| Q1 24 | 34.0% | 38.1% |
| Q4 25 | 19.8% | 10.1% | ||
| Q3 25 | 20.4% | 14.6% | ||
| Q2 25 | 20.1% | 13.9% | ||
| Q1 25 | 20.4% | 7.8% | ||
| Q4 24 | 19.8% | 8.8% | ||
| Q3 24 | 20.0% | 12.3% | ||
| Q2 24 | 19.6% | 11.0% | ||
| Q1 24 | 17.4% | 8.4% |
| Q4 25 | 14.9% | 7.0% | ||
| Q3 25 | 15.1% | 12.7% | ||
| Q2 25 | 15.0% | 8.7% | ||
| Q1 25 | 14.8% | 4.4% | ||
| Q4 24 | 14.0% | 6.5% | ||
| Q3 24 | 14.1% | 8.3% | ||
| Q2 24 | 13.7% | 6.5% | ||
| Q1 24 | 12.1% | 4.9% |
| Q4 25 | $1.21 | $0.41 | ||
| Q3 25 | $1.24 | $0.78 | ||
| Q2 25 | $1.17 | $0.55 | ||
| Q1 25 | $1.13 | $0.22 | ||
| Q4 24 | $1.03 | $0.38 | ||
| Q3 24 | $1.03 | $0.48 | ||
| Q2 24 | $0.98 | $0.38 | ||
| Q1 24 | $0.89 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $71.3M |
| Total DebtLower is stronger | — | $181.6M |
| Stockholders' EquityBook value | $1.3B | $640.7M |
| Total Assets | $1.7B | $1.2B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $71.3M | ||
| Q3 25 | $65.1M | $187.4M | ||
| Q2 25 | $65.4M | $121.7M | ||
| Q1 25 | $49.9M | $97.8M | ||
| Q4 24 | $49.5M | $99.2M | ||
| Q3 24 | $73.7M | $115.6M | ||
| Q2 24 | $63.7M | $94.2M | ||
| Q1 24 | $60.3M | $89.8M |
| Q4 25 | — | $181.6M | ||
| Q3 25 | — | $307.8M | ||
| Q2 25 | — | $304.4M | ||
| Q1 25 | — | $302.9M | ||
| Q4 24 | — | $302.8M | ||
| Q3 24 | — | $337.9M | ||
| Q2 24 | — | $387.6M | ||
| Q1 24 | — | $391.8M |
| Q4 25 | $1.3B | $640.7M | ||
| Q3 25 | $1.3B | $621.0M | ||
| Q2 25 | $1.3B | $575.0M | ||
| Q1 25 | $1.2B | $513.1M | ||
| Q4 24 | $1.1B | $489.1M | ||
| Q3 24 | $1.2B | $501.6M | ||
| Q2 24 | $1.1B | $451.2M | ||
| Q1 24 | $1.1B | $428.5M |
| Q4 25 | $1.7B | $1.2B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.6B | $1.2B | ||
| Q4 24 | $1.6B | $1.2B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.6B | $1.2B | ||
| Q1 24 | $1.6B | $1.2B |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | — | 0.91× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $49.3M |
| Free Cash FlowOCF − Capex | — | $28.6M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | — | 5.9% |
| Cash ConversionOCF / Net Profit | 1.72× | 2.02× |
| TTM Free Cash FlowTrailing 4 quarters | — | $121.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $49.3M | ||
| Q3 25 | $65.6M | $76.7M | ||
| Q2 25 | $47.3M | $30.1M | ||
| Q1 25 | $36.5M | $11.7M | ||
| Q4 24 | $52.3M | $38.0M | ||
| Q3 24 | $51.3M | $76.2M | ||
| Q2 24 | $45.0M | $21.5M | ||
| Q1 24 | $33.4M | $12.6M |
| Q4 25 | — | $28.6M | ||
| Q3 25 | — | $66.1M | ||
| Q2 25 | — | $22.8M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | — | $24.4M | ||
| Q3 24 | — | $69.7M | ||
| Q2 24 | — | $12.0M | ||
| Q1 24 | — | $8.6M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 20.3% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | 1.72× | 2.02× | ||
| Q3 25 | 1.63× | 1.66× | ||
| Q2 25 | 1.23× | 0.93× | ||
| Q1 25 | 0.98× | 0.90× | ||
| Q4 24 | 1.56× | 1.75× | ||
| Q3 24 | 1.52× | 2.68× | ||
| Q2 24 | 1.40× | 0.95× | ||
| Q1 24 | 1.15× | 0.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
TILE
| AMS | $205.9M | 59% |
| EAAA | $143.5M | 41% |
